Related Experiment Video

Updated: Oct 2, 2026

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

Unstable angina pectoris. Platelet behavior and prognosis in progressive angina and intermediate coronary syndrome

P Grande1, A M Grauholt, J K Madsen

  • 1Medical Department B (Cardiology), Rigshospitalet, University Hospital, Copenhagen, Denmark.

Circulation
|January 1, 1990
PubMed

Insights

Patients with intermediate coronary syndrome exhibit hyperaggregating platelets and elevated thromboxane B2, indicating altered platelet behavior. This contrasts with progressive angina patients, suggesting distinct pathophysiological mechanisms for unstable angina.

Area of Science:

  • Cardiology
  • Hematology
  • Thrombosis

Background:

  • Unstable angina encompasses conditions like intermediate coronary syndrome (rest pain, ST depression) and progressive angina.
  • Platelet activation plays a critical role in the pathophysiology of acute coronary syndromes.
  • Understanding distinct platelet behavior in different unstable angina subsets is crucial for prognosis and treatment.

Purpose of the Study:

  • To compare platelet aggregation and activation markers in patients with intermediate coronary syndrome versus progressive angina.
  • To assess platelet behavior in relation to healthy controls.

Main Methods:

  • Ex vivo platelet aggregation assay using arachidonic acid.
  • Measurement of serum thromboxane B2, plasma beta-thromboglobulin, and platelet factor 4.
  • Comparison between 13 intermediate coronary syndrome patients, 14 progressive angina patients, and 20 healthy controls.

Main Results:

  • Both unstable angina groups showed hyperaggregating platelets compared to controls (p < 0.01).
  • Intermediate coronary syndrome patients had significantly increased serum thromboxane B2, plasma beta-thromboglobulin, and platelet factor 4 (p < 0.01).
  • Progressive angina patients did not show significantly different levels of these markers compared to controls.

Conclusions:

  • Patients with intermediate coronary syndrome exhibit severely altered platelet behavior, characterized by hyperaggregation and increased activation markers.
  • These platelet changes in intermediate coronary syndrome are distinct from those observed in progressive angina.
  • Altered platelet behavior in intermediate coronary syndrome may correlate with a higher frequency of coronary artery thrombus and poorer prognosis.

More Related Videos

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function10:28

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function

Published on: March 15, 2022

Related Concept Videos

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina I: Introduction01:30

Angina I: Introduction

Definition and Symptoms: Angina (angina pectoris) is chest pain or discomfort caused by myocardial ischemia, which occurs when the heart muscle receives insufficient oxygen-rich blood. It typically manifests as pressing, squeezing, or crushing sensations in the chest and may radiate to the shoulders, arms, neck, jaw, or back.Primary Cause: In a healthy state, the coronary arteries can dilate (widen) to increase blood flow and meet the increased oxygen demand during physical activity or...
Angina II: Classification01:27

Angina II: Classification

Angina, also known as angina pectoris, is a chest pain resulting from diminished blood flow to the heart muscle and is often a symptom of coronary artery disease. Angina presents several variants with distinctive attributes, etiologies, and therapeutic approaches. The main types of angina include stable, unstable, variant (Prinzmetal's), microvascular, intractable, and silent ischemia.Stable angina is caused by atherosclerosis, which leads to the formation of plaques that narrow the coronary...
Angina III: Clinical Manifestations and Assessment01:29

Angina III: Clinical Manifestations and Assessment

Angina manifests as chest pain, tightness, or squeezing discomfort typically located behind the breastbone. It can radiate to the neck, jaw, shoulders, and inner aspects of the upper arms, most commonly the left arm. Patients may experience shortness of breath, fatigue, profuse sweating, dizziness, indigestion, heartburn, palpitations, anxiety, and vomiting as accompanying symptoms. This pain often lasts a few minutes and is triggered by physical exertion, emotional stress, heavy meals, or cold...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...